In accordance with the instructions and rules of procedure for the Nomination Committee adopted by the Annual General Meeting, the Nomination Committee of Mentice AB (publ) shall consist of the Chairman of the Board and three members representing the three largest shareholders by voting power as of September 30.

The following persons have been appointed to the Nomination Committee for the
Annual General Meeting 2026 in Mentice:

Lawrence D Howell, appointed by Karin Howell,
Sophie Hagströmer, appointed by Bure Equity,
Thomas Ehlin, appointed by Fjärde AP-Fonden, and
Magnus Nilsson, Chairman of the Board in Mentice AB (publ).

Magnus Nilsson, is the convener of the first meeting of the Nomination Committee.
The Nomination Committee represents approximately 56,3 percent of the total number of outstanding shares and votes.

The Nomination Committee shall, inter alia, prepare and submit the following proposals to the Annual General Meeting:

• Election of a Chairman of the meeting
• Decision on the number of Board members
• Decision on remuneration to the Board members and to the Auditor
• Election of Board members and Chairman of the Board
• Decision on principles for appointing Nomination Committee

The Annual General Meeting will occur in Gothenburg on 26 May 2026. Shareholders who have proposals for the Annual General Meeting are asked to submit them to the Nomination Committee by email to ir@mentice.com or by letter to Mentice AB (publ), The Nomination Committee, Odinsgatan 10, 411 03 Gothenburg.

In order for the Nomination Committee to process the received proposals with sufficient care, proposals must be submitted no later than 7 April 2026

For more information, please contact:
Frans Venker, CEO, Mentice
Email: frans.venker@mentice.com
Mobile +46 (0) 735 25 30 81

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Premium Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Attachments
Nomination Committee has been appointed for Mentice AB (publ) Annual General Meeting 2026

Läs mer på MFN